Drug cominbations containing AZT
US6365578B1 · kind B1 · utility
1Cited by
3References
6Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Jul 6, 1993 |
| Grant date | Apr 2, 2002 |
| Priority date | — |
| Expiry date | Jul 6, 2013 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61K31/505
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
Combinations of 3′-azido-3′-deoxythymidine (AZT) with 5-fluorouracil (FUra) or its precursor 5-fluoro-2′-deoxyuridine (FUDR) or methoxtrexate (MTX) exhibit increased cytotoxicity and increased therapeutic index in treatment of carcinomas.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.